Determinants of parathyroid hormone response to Vitamin D supplementation: A systematic review and meta-analysis of randomised controlled trials

British Journal of Nutrition

Volumn 114, Issue 9, 2015, Pages 1360-1374

  Moslehi, Nazanin ^a   Shab Bidar, Sakineh ^b   Mirmiran, Parvin ^c   Hosseinpanah, Farhad ^d   Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cholecalciferol; Meta analyses; Parathyroid hormone; Randomised controlled trials; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; ERGOCALCIFEROL; PARATHYROID HORMONE; VITAMIN D;

ARTICLE; BODY MASS; FOLLOW UP; HORMONE RESPONSE; HUMAN; META ANALYSIS; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; SUPPLEMENTATION; SYSTEMATIC REVIEW; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; BLOOD; DIET SUPPLEMENTATION; OVERWEIGHT;

DIETARY SUPPLEMENTS; HUMANS; OBESITY; OVERWEIGHT; PARATHYROID HORMONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D;

EID: 84944276138     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515003189     Document Type: Article

References (99)

1. Holick MF (2007) Vitamin D deficiency. New Engl J Med 357, 266-281.
2. Dawson-Hughes B, Heaney RP, Holick MF, et al. (2005) Estimates of optimal vitamin D status. Osteoporos Int 16, 713-716.
3. Bouillon R, Van Schoor NM, Gielen E, et al. (2013) Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab 98, E1283-E1304.
4. Aloia JF (2011) The 2011 report on dietary reference intake for vitamin D: where do we go from here? J Clin Endocrinol Metab 96, 2987-2996.
5. 3 supplementation: a meta-regression analysis Nutrition 30, 975-985.
6. Bates C, Carter G, Mishra G, et al. (2003) In a population study, can parathyroid hormone aid the definition of adequate vitamin D status? A study of people aged 65 years and over from the British National Diet and Nutrition Survey. Osteo-poros Int 14, 152-159.
7. Sai A, Walters R, Fang X, et al. (2010) Relationship between vitamin D, parathyroid hormone, and bone health. Clin Endocrinol Metab 96, E436-E446.
8. Björkman M, Sorva A & Tilvis R (2009) Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials. Arch Gerontol Geriatr 48, 160-166.
9. Moher D, Liberati A, Tetzlaff J, et al. (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Int Med 151, 264-269.
10. Richter B & Berger M (2000) Randomized controlled trials remain fundamental to clinical decision making in type II diabetes mellitus: a comment to the debate on randomized controlled trials. Diabetologia. 43, 254-258.
11. Ross AC, Taylor CL, Yaktine AL, et al. (editors) (2011) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Washington, DC: National Academies Press.
12. 2. Am J Clin Nutr 68, 854-858.
13. 3 in humans. J Clin Endocrinol Metab 89, 5387-5391.
14. 3. J Am Coll Nutr 21, 357-362.
15. 3 do the elderly need? J Am Coll Nutr 25, 429-435.
16. Moher D, Klassen TP, Schulz KF, et al. (2000) What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol 53, 964-972.
17. Jüni P, Holenstein F, Sterne J, et al. (2002) Direction and impact of language bias in meta-analyses of controlled trials: empirical study Int J Epidemiol 31, 115-123.
18. Steinberg K, Smith S, Stroup D, et al. (1997) Comparison of effect estimates from a meta-analysis of summary data from published studies and from a meta-analysis using individual patient data for ovarian cancer studies. Am J Epidemiol 145, 917-925.
19. Jadad AR, Moore RA, Carroll D, et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 17, 1-12.
20. Cochran W (1954) The combination of estimates from different experiments. Biometrics 8, 101-129.
21. DerSimonian R & Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7, 177-188.
22. Lau J, Antman EM, Jimenez-Silva J, et al. (1992) Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327, 248-254.
23. Egger M, Davey Smith G, Schneider M, et al. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634.
24. Duval S & Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56, 455-463.
25. Suzuki M, Yoshioka M, Hashimoto M, et al. (2013) Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr 97, 1004-1013.
26. Chapuy MC, Chapuy P & Meunier PJ (1987) Calcium and vitamin D supplements: effects on calcium metabolism in elderly people. Am J Clin Nutr 46, 324-328.
27. Dawson-Hughes B, Dallal GE, Krall EA, et al. (1991) Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 115, 505-512.
28. 3 and calcium to prevent hip fractures in the elderly women. NEngl J Med 327, 1637-1642.
29. Ooms ME, Roos JC, Bezemer PD, et al. (1995) Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 80, 1052-1058.
30. Dawson-Hughes B, Harris SS, Krall EA, et al. (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337, 670-676.
31. 3 and calcium on quantitative ultrasound of bone in elderly institutionalized women: a longitudinal study. Osteoporos Int 9, 483-488.
32. Hunter D, Major P, Arden N, et al. (2000) A randomized controlled trial of vitamin D supplementation on preventing postmenopausal bone loss and modifying bone metabolism using identical twin pairs. JBone Miner Res 15, 2276-2283.
33. Pfeifer M, Begerow B, Minne HW, et al. (2001) Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 86, 1633-1637.
34. Kenny AM, Biskup B, Robbins B, et al. (2003) Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J Am Geriatr Soc 51, 1762-1767.
35. Grados F, Brazier M, Kamel S, et al. (2003) Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation. J Clin Endocrinol Metab 88, 5175-5179.
36. Bischoff HA, Stahelin HB, Dick W, et al. (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18, 343-351.
37. Brazier M, Grados F, Kamel S, et al. (2005) Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 27, 1885-1893.
38. Talwar SA, Aloia JF, Pollack S, et al. (2007) Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr 86, 1657-1662.
39. Pittas AG, Harris SS, Stark PC, et al. (2007) The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30, 980-986.
40. Sneve M, Figenschau Y & Jorde R (2008) Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 159, 675-684.
41. Chel V, Wijnhoven HA, Smit JH, et al. (2008) Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 19, 663-671.
42. Bjorkman M, Sorva A, Risteli J, et al. (2008) Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients. Age Ageing 37, 25-31.
43. Cashman KD, Hill TR, Lucey AJ, et al. (2008) Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr 88, 1535-1542.
44. Pfeifer M, Begerow B, Minne HW, et al. (2009) Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 20, 315-322.
45. Zittermann A, Frisch S, Berthold HK, et al. (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89, 1321-1327.
46. Islam MZ, Shamim AA, Viljakainen HT, et al. (2010) Effect of vitamin D, calcium and multiple micronutrient supplementation on vitamin D and bone status in Bangladeshi premenopausal garment factory workers with hypovitaminosis D: a double-blinded, randomised, placebo-controlled 1-year intervention. Br J Nutr 104, 241-247.
47. Jorde R, Sneve M, Torjesen P, et al. (2010) Parameters of the thrombogram are associated with serum 25-hydroxyvitamin D levels at baseline, but not affected during supplementation with vitamin D. Thromb Res 125, e210-e213.
48. Lips P, Binkley N, Pfeifer M, et al. (2010) Once-weekly dose of 8400 IU vitamin D(3) compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency. Am J Clin Nutr 91, 985-991.
49. Grimnes G, Figenschau Y, Almas B, et al. (2011) Vitamin D, insulin secretion, sensitivity, and lipids: results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique. Diabetes 60, 2748-2757.
50. Chung HY, Chin SO, Kang MI, et al. (2011) Efficacy of risedronate with cholecalciferol on 25-hydroxyvitamin D level and bone turnover in Korean patients with osteoporosis. Clin Endocrinol (Oxf) 74, 699-704.
51. Sokol SI, Srinivas V, Crandall JP, et al. (2012) The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med 17, 394-404.
52. Ponda MP, Dowd K, Finkielstein D, et al. (2012) The short-term effects of vitamin D repletion on cholesterol: a randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 32, 2510-2515.
53. Harris SS, Pittas AG & Palermo NJ (2012) A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes Metab 14, 789-794.
54. Larsen T, Mose FH, Bech JN, et al. (2012) Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 25, 1215-1222.
55. Kjaergaard M, Waterloo K, Wang CE, et al. (2012) Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry 201, 360-368.
56. Salehpour A, Hosseinpanah F, Shidfar F, et al. (2012) A 12-week double-blind randomized clinical trial of vitamin D (3) supplementation on body fat mass in healthy overweight and obese women. Nutr J 11, 78.
57. Goswami R, Vatsa M, Sreenivas V, et al. (2012) Skeletal muscle strength in young Asian Indian females after vitamin D and calcium supplementation: a double-blind randomized controlled clinical trial. J Clin Endocrinol Metab 97, 4709-4716.
58. Suzuki M, Yoshioka M, Hashimoto M, et al. (2013) Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr 97, 1004-1013.
59. Ooms ME, Lips P, Roos JC, et al. (1995) Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res 10, 1177-1184.
60. 3 supplementation on body fat mass in healthy overweight and obese women. Nutr J 11, 78.
61. Bjorkman M, Sorva A & Tilvis R (2008) Vitamin D supplementation has no major effect on pain or pain behavior in bedridden geriatric patients with advanced dementia. Aging Clin Exp Res 20, 316-321.
62. Dawson-Hughes B, Harris SS, Krall EA, et al. (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. New Engl J Med 337, 670-676.
63. Jorde R, Sneve M, Torjesen PA, et al. (2010) No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 50, 175-180.
64. Bischoff HA, Stähelin HB, Dick W, et al. (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 8, 343-351.
65. 3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women 1. J Clin Endocrinol Metab 86, 1633-1637.
66. Brazier M, Grados F, Kamel S, et al. (2005) Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a mlticenter, randomized, double-blind, placebo-controlled study. Clin Ther 27, 1885-1893.
67. Chapuy M, Chapuy P & Meunier P (1987) Calcium and vitamin D supplements: effects on calcium metabolism in elderly people. Am J Clin Nutr 46, 324-328.
68. 3 and calcium to prevent hip fractures in elderly women. New Engl J Med 327, 1637-1642.
69. Kenny AM, Biskup B, Robbins B, et al. (2003) Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J Am Geriatr Soc 51, 1762-1767.
70. Grados F, Brazier M, Kamel S, et al. (2003) Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation. J Clin Endocrinol Metab 88, 5175-5179.
71. Ooms ME, Roos J, Bezemer PD, et al. (1995) Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 80, 1052-1058.
72. Dawson-Hughes B, Dallal GE, Krall EA, et al. (1991) Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Int Med 115, 505-512.
73. Hunter D, Major P, Arden N, et al. (2000) A randomized controlled trial of vitamin D supplementation on preventing postmenopausal bone loss and modifying bone metabolism using identical twin pairs. J Bone Min Res 15, 2276-2283.
74. Cranney A, Horsley T, O'Donnell S, et al. (2007) Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 158, 1-235.
75. Gallagher JC, Sai A, Templin T, et al. (2012) Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Int Med 156, 425-437.
76. Heaney RP, Davies KM, Chen TC, et al. (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77, 204-210.
77. Vieth R, Bischoff-Ferrari H, Boucher BJ, et al. (2007) The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 85, 649-650.
78. Holick MF (2006) The role of vitamin D for bone health and fracture prevention. Curr Osteoporos Rep 4, 96-102.
79. Lips P, Duong T, Oleksik A, et al. (2001) A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endo-crinol Metab 86, 1212-1221.
80. Steingrimsdottir L, Gunnarsson O, Indridason OS, et al. (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294, 2336-2341.
81. Seamans KM & Cashman KD (2009) Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr 89, 1997S-2008S.
82. Baron J, Beach MF, Mandel J, et al. (1999) Calcium supplements for the prevention of colorectal adenomas. New Engl J Med 340, 101-107.
83. Weaver CM & Fleet JC (2004) Vitamin D requirements: current and future. Am J Clin Nutr 80, 1735S-1739S.
84. Aloia JF, Talwar SA, Pollack S, et al. (2006) Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr 84, 602-609.
85. Heaney R & Feldman D (1997) Vitamin D: role in the calcium economy. In Vitamin D, pp. 485-497. San Diego, CA: Academic Press.
86. Lips P (2004) Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 89, 611-614.
87. Lips P (2001) Vitamin D deficiency and secondary hyper-parathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22, 477-501.
88. Sai A, Walters R, Fang X, et al. (2010) Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab 96, E436-E446.
89. Gloth F 3rd, Tobin J, Sherman S, et al. (1991) Is the recommended daily allowance for vitamin D too low for the homebound elderly? J Am Geriatr Soc 39, 137.
90. Dixon T, Mitchell P, Beringer T, et al. (2006) An overview of the prevalence of 25-hydroxy-vitamin D inadequacy amongst elderly patients with or without fragility fracture in the United Kingdom. Curr Med Res Opin 22, 2, 405-415.
91. 3. J Clin Invest 76, 1536.
92. Holick MF, Matsuoka LY & Wortsman J (1989) Age, vitamin D, and solar ultraviolet. Lancet 334, 1104-1105.
93. Vieth R, Ladak Y & Walfish PG (2003) Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88, 185-191.
94. Bell NH, Epstein S, Greene A, et al. (1985) Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76, 370.
95. Bolland MJ, Grey AB, Ames RW, et al. (2006) Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. Bone 38, 317-321.
96. Snijder MB, van Dam RM, Visser M, et al. (2005) Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 90, 4119-4123.
97. Wortsman J, Matsuoka LY, Chen TC, et al. (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72, 690-693.
98. Shapses SA, Lee EJ, Sukumar D, et al. (2013) The effect of obesity on the relationship between serum parathyroid hormone and 25-hydroxyvitamin D in women. J Clin Endocrinol Metab 98, E886-E890.
99. Macdonald HM, Mavroeidi A, Barr RJ, et al. (2008) Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. Bone 42, 996-1003.